Neuromet, 45 mg capsules 30 pcs

Nootropic, has metabolic and trophic effect.

Increases metabolic processes in the brain by activation of glucose and adenosine triphosphate (ATP) synthesis, improves blood supply and oxygenation of brain tissue, promotes lactate excretion; increases intensity and speed of neurophysiological reactions of brain structures.

Inhibiting lipid peroxidation protects membranes of neurons and mitochondria from damage.

From the first days of use antiestrogenic, psychostimulant and antidepressant effect, nootropic effect appears after 3-4 weeks of use.

Indications

– Psycho-organic syndrome on the background of impaired cerebral circulation and age-related involutionary changes of the brain;

– Cerebroasthenic disorders of vascular, traumatic, psychogenic (neurasthenia) etiology: Memory and/or attention disorders, decreased intellectual productivity and general activity, emotional instability;

– Asthenic and asthenodepressive syndrome, moderately pronounced depressive syndrome; dizziness, tinnitus.

Active ingredient

Composition

1 capsule contains:

the active ingredient:

idebenone 45 mg;

auxiliary substances:

Potato starch,

Lactose (milk sugar),

Microcrystalline cellulose,

povidone (polyvinylpyrrolidone),

crospovidone (Polyplasdon X El-10),

magnesium stearate.

Composition of hard gelatin capsule

for a dosage of 45 mg:

titanium dioxide (E171),

red iron oxide (E 172),

black iron oxide (E 172),

p> quinoline yellow dye (E 104),

sunset yellow dye (E110),

azorubin (E 122),

gelatin.

Directions for use

Ingestion, 30-45 mg 2-3 times a day, after meals (last dose before 5 p.m.).

The course of treatment is 1.5-2 months. If necessary, 2-3 courses per year.

Synopsis

Solid gelatin capsules № 0 – Yellow body, brown cap.

The content of the capsules is a granulate containing pellets or powder of yellow or yellow-orange color with orange and white flecks.

Features

Contraindications

Hypersensitivity, chronic renal failure.

Side effects

Overdose

Symptoms: increased severity of side effects.

Treatment: If necessary, administer activated charcoal and symptomatic therapy.

Influence on ability to drive vehicles and vehicles:

During treatment it is necessary to refrain from driving motor transport and other potentially dangerous activities that require high concentration and quick psychomotor reactions.
.